XML 120 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - (Tables)
12 Months Ended
Jan. 02, 2021
Share-based Payment Arrangement [Abstract]  
Number and Weighted Average Exercise Price of Options Issued and Outstanding under All Stock Option Plans
The number and weighted-average exercise price of options issued and outstanding under all of the Company’s equity plans are as follows (in thousands, except for weighted-average exercise prices):
Year Ended
January 2,
2021
Year Ended
December 28,
2019
Year Ended
December 29,
2018
SharesAverage
Exercise
Price
SharesAverage
Exercise
Price
SharesAverage
Exercise
Price
Options outstanding, beginning of period5,212 $54.23 5,676 $43.61 6,953 $36.26 
Granted400 187.83 545 140.56 564 98.47 
Canceled/Forfeited(219)126.98 (158)83.14 (233)67.45 
Exercised(1,945)32.41 (851)33.32 (1,608)27.62 
Options outstanding, end of period3,448 $77.44 5,212 $54.23 5,676 $43.61 
Options exercisable, end of period2,026 $47.31 3,311 $33.80 3,273 $29.63 
Number and Weighted Average Exercise Price of Outstanding and Exercisable Options
The number and weighted-average exercise price of outstanding and exercisable stock options segregated by exercise price ranges (in thousands, except range of exercise prices and remaining contractual life) were as follows:
Year Ended
January 2,
2021
Year Ended
December 28,
2019
Options OutstandingOptions
Exercisable
Options OutstandingOptions
Exercisable
Range of Exercise PricesNumber of
Options
Average
Remaining
Contractual
Life
Number of
Options
Number of
Options
Average
Remaining
Contractual
Life
Number of
Options
$15.00 to $50.00
1,696 4.141,518 3,464 4.142,958 
$50.01 to $80.00
42 5.8026 68 5.5630 
$80.01 to $120.00
910 6.83408 1,148 6.98320 
$120.01 to $160.00
476 8.4174 532 8.46
$160.01 to $200.00
255 9.17— — 0.00— 
$200.01 to $230.00
37 9.50— — 0.00— 
$230.01 to $275.00
32 9.53— — 0.00— 
     Total3,448 5.902,026 5,212 5.603,311 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The number of RSUs issued and outstanding under all of the Company’s equity plans are as follows (in thousands, except for weighted average grant date fair value amounts):
Year Ended
January 2,
2021
Year Ended
December 28,
2019
Year Ended
December 29,
2018
UnitsWeighted Average
Grant Date
Fair Value
UnitsWeighted Average
Grant Date
Fair Value
UnitsWeighted Average
Grant Date
Fair Value
RSUs outstanding, beginning of period2,797 $96.85 2,707 $95.54 2,708 $95.51 
Granted98 193.77 100 133.57 99.05 
Canceled/Forfeited(6)165.03 (3)133.50 — — 
Vested(27)134.78 (7)99.05 (8)88.40 
RSUs outstanding, end of period2,862 $99.66 2,797 $96.85 2,707 $95.54 
Schedule of Nonvested Performance-based Units Activity
The number of PSUs outstanding under all of the Company’s equity plans are as follows (in thousands, except for weighted average grant date fair value amounts):
Year Ended
January 2,
2021
Year Ended
December 28,
2019
Year Ended
December 29,
2018
UnitsWeighted Average
Grant Date
Fair Value
UnitsWeighted Average
Grant Date
Fair Value
UnitsWeighted Average
Grant Date
Fair Value
PSUs outstanding, beginning of period412 $102.22 313 $88.34 233 $90.70 
Granted97 179.42 128 133.50 197 86.95 
Canceled/Forfeited(7)122.13 — — (86)90.71 
Vested(58)90.69 (29)90.69 (31)90.70 
PSUs outstanding, end of period444 $120.28 412 $102.22 313 $88.34 
Range of Assumptions Used and Resulting Weighted-Average Fair Value of Options Granted at Date of Grant The range of assumptions used and the resulting weighted-average fair value of options granted at the date of grant were as follows:
Year Ended
January 2,
2021
Year Ended
December 28,
2019
Year Ended
December 29,
2018
Risk-free interest rate
0.2% to 1.7%
1.4% to 2.6%
2.3% to 3.1%
Expected term
5.1 years to 5.1 years
5.1 years to 5.2 years
5.2 years to 5.6 years
Estimated volatility
26.9% to 35.5%
28.2% to 30.0%
26.8% to 32.0%
Expected dividends0%0%0%
Weighted-average fair value of options granted$51.10 per share$42.29 per share$31.85 per share
Total Share-Based Compensation Expense Included in Consolidated Statements of Comprehensive Income
The following table presents the total stock-based compensation expense that is included in each functional line item of the consolidated statements of operations (in thousands):
Year Ended
January 2,
2021
Year Ended
December 28,
2019
Year Ended
December 29,
2018
Cost of goods sold$714 $445 $334 
Selling, general and administrative31,462 30,450 21,391 
Research and development10,049 8,340 5,692 
Total
$42,225 $39,235 $27,417